Fortrea Holdings (FTRE) Other Operating Expenses (2022 - 2026)
Fortrea Holdings (FTRE) posted Other Operating Expenses of $539.4 million for Q1 2026, down 5.55% on a QoQ basis from $571.1 million in Q4 2025, and down 48.61% year-over-year from $1.0 billion in Q1 2025.
Fortrea Holdings (FTRE) Other Operating Expenses (2022 - 2026) Analysis & Trends
Fortrea Holdings' Other Operating Expenses history runs 5 years deep, the most recent figure standing at $539.4 million for Q1 2026.
- Quarterly Other Operating Expenses fell 48.61% year-over-year to $539.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.6 billion (down 5.0% YoY) and the FY2025 annual result came in at $3.1 billion, up 36.65% from the prior year.
- Other Operating Expenses was $539.4 million for Q1 2026 at Fortrea Holdings, down from $571.1 million in the prior quarter.
- Across five years, Other Operating Expenses topped out at $1.0 billion in Q1 2025 and bottomed at $286.0 million in Q4 2022.
- A 5-year average of $616.1 million and a median of $588.4 million in 2023 frame the typical range for Other Operating Expenses.
- Annual changes were most pronounced in 2023 — Other Operating Expenses soared 109.58% — and 2026, when it sank 48.61%.
- Fortrea Holdings' Other Operating Expenses stood at $286.0 million in 2022, then surged by 109.58% to $599.4 million in 2023, then advanced by 0.85% to $604.5 million in 2024, then fell by 5.53% to $571.1 million in 2025, then dropped by 5.55% to $539.4 million in 2026.
- Business Quant data shows FTRE's Other Operating Expenses at $539.4 million in Q1 2026, $571.1 million in Q4 2025, and $603.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Fortrea Holdings | 1.83 Bn | 1.68 Bn | 123.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 539.40 Mn |
| Dec 31, 2025 | 571.10 Mn |
| Sep 30, 2025 | 603.10 Mn |
| Jun 30, 2025 | 915.80 Mn |
| Mar 31, 2025 | 1.05 Bn |
| Dec 31, 2024 | 604.50 Mn |
| Sep 30, 2024 | 556.60 Mn |
| Jun 30, 2024 | 557.10 Mn |
| Mar 31, 2024 | 579.40 Mn |
| Dec 31, 2023 | 599.40 Mn |
| Sep 30, 2023 | 585.10 Mn |
| Jun 30, 2023 | 591.80 Mn |
| Mar 31, 2023 | 563.00 Mn |
| Dec 31, 2022 | 286.00 Mn |
| Sep 30, 2022 | 617.50 Mn |
| Jun 30, 2022 | 637.70 Mn |